Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders

Sherie Novotny, Eric Hollander, Ann Phillips, Andrea Allen, Stacey Wasserman, Rupa Iyengar

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Autism is a neurodevelopmental disorder characterized by dysfunction in three primary behavioural domains: repetitive behaviours, social deficits, and language abnormalities. There is evidence that abnormalities exist in the serotonin (5-HT) system in autism spectrum patients. Furthermore, 5-HT is known to play a role in repetitive and social behaviours. This study examined the effect of m-chlorophenylpiperazine (m-CPP) on repetitive behaviours and prolactin response in 11 adults with autism or Asperger's disorder and 8 age- and gender-matched healthy controls via randomized double-blind, m-CPP and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviours: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant increase in repetitive behaviours at end-point following oral m-CPP in comparison to placebo. Additionally subjects with autism spectrum disorders showed a significantly increased prolactin response to m-CPP compared to normal controls, with neither group responding to placebo. This study provides further evidence for altered 5-HT sensitivity in individuals with autism spectrum disorders, as well as a possible relationship between repetitive behaviours in autism spectrum disorders and abnormalities in the 5-HT system.

Original languageEnglish (US)
Pages (from-to)249-254
Number of pages6
JournalInternational Journal of Neuropsychopharmacology
Volume7
Issue number3
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Prolactin
Serotonin
Autistic Disorder
Placebos
Asperger Syndrome
Social Behavior
Language
Outcome Assessment (Health Care)
Autism Spectrum Disorder
1-(3-chlorophenyl)piperazine
Wounds and Injuries

Keywords

  • Asperger's disorder
  • Autism
  • Obsessive-compulsive behaviours
  • Oxytocin
  • Peptide

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. / Novotny, Sherie; Hollander, Eric; Phillips, Ann; Allen, Andrea; Wasserman, Stacey; Iyengar, Rupa.

In: International Journal of Neuropsychopharmacology, Vol. 7, No. 3, 09.2004, p. 249-254.

Research output: Contribution to journalArticle

@article{59209ad98e9548a085ed41d1f8931475,
title = "Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders",
abstract = "Autism is a neurodevelopmental disorder characterized by dysfunction in three primary behavioural domains: repetitive behaviours, social deficits, and language abnormalities. There is evidence that abnormalities exist in the serotonin (5-HT) system in autism spectrum patients. Furthermore, 5-HT is known to play a role in repetitive and social behaviours. This study examined the effect of m-chlorophenylpiperazine (m-CPP) on repetitive behaviours and prolactin response in 11 adults with autism or Asperger's disorder and 8 age- and gender-matched healthy controls via randomized double-blind, m-CPP and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviours: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant increase in repetitive behaviours at end-point following oral m-CPP in comparison to placebo. Additionally subjects with autism spectrum disorders showed a significantly increased prolactin response to m-CPP compared to normal controls, with neither group responding to placebo. This study provides further evidence for altered 5-HT sensitivity in individuals with autism spectrum disorders, as well as a possible relationship between repetitive behaviours in autism spectrum disorders and abnormalities in the 5-HT system.",
keywords = "Asperger's disorder, Autism, Obsessive-compulsive behaviours, Oxytocin, Peptide",
author = "Sherie Novotny and Eric Hollander and Ann Phillips and Andrea Allen and Stacey Wasserman and Rupa Iyengar",
year = "2004",
month = "9",
doi = "10.1017/S146114570400433X",
language = "English (US)",
volume = "7",
pages = "249--254",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "3",

}

TY - JOUR

T1 - Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders

AU - Novotny, Sherie

AU - Hollander, Eric

AU - Phillips, Ann

AU - Allen, Andrea

AU - Wasserman, Stacey

AU - Iyengar, Rupa

PY - 2004/9

Y1 - 2004/9

N2 - Autism is a neurodevelopmental disorder characterized by dysfunction in three primary behavioural domains: repetitive behaviours, social deficits, and language abnormalities. There is evidence that abnormalities exist in the serotonin (5-HT) system in autism spectrum patients. Furthermore, 5-HT is known to play a role in repetitive and social behaviours. This study examined the effect of m-chlorophenylpiperazine (m-CPP) on repetitive behaviours and prolactin response in 11 adults with autism or Asperger's disorder and 8 age- and gender-matched healthy controls via randomized double-blind, m-CPP and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviours: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant increase in repetitive behaviours at end-point following oral m-CPP in comparison to placebo. Additionally subjects with autism spectrum disorders showed a significantly increased prolactin response to m-CPP compared to normal controls, with neither group responding to placebo. This study provides further evidence for altered 5-HT sensitivity in individuals with autism spectrum disorders, as well as a possible relationship between repetitive behaviours in autism spectrum disorders and abnormalities in the 5-HT system.

AB - Autism is a neurodevelopmental disorder characterized by dysfunction in three primary behavioural domains: repetitive behaviours, social deficits, and language abnormalities. There is evidence that abnormalities exist in the serotonin (5-HT) system in autism spectrum patients. Furthermore, 5-HT is known to play a role in repetitive and social behaviours. This study examined the effect of m-chlorophenylpiperazine (m-CPP) on repetitive behaviours and prolactin response in 11 adults with autism or Asperger's disorder and 8 age- and gender-matched healthy controls via randomized double-blind, m-CPP and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviours: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant increase in repetitive behaviours at end-point following oral m-CPP in comparison to placebo. Additionally subjects with autism spectrum disorders showed a significantly increased prolactin response to m-CPP compared to normal controls, with neither group responding to placebo. This study provides further evidence for altered 5-HT sensitivity in individuals with autism spectrum disorders, as well as a possible relationship between repetitive behaviours in autism spectrum disorders and abnormalities in the 5-HT system.

KW - Asperger's disorder

KW - Autism

KW - Obsessive-compulsive behaviours

KW - Oxytocin

KW - Peptide

UR - http://www.scopus.com/inward/record.url?scp=4444283450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444283450&partnerID=8YFLogxK

U2 - 10.1017/S146114570400433X

DO - 10.1017/S146114570400433X

M3 - Article

C2 - 15132762

AN - SCOPUS:4444283450

VL - 7

SP - 249

EP - 254

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 3

ER -